Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Solari

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Antiviral Chemistry & Chemotherapy|April 20, 2013
The application of prophylactic antibodies for rhinovirus infectionsRiccardo Privolizzi, Roberto Solari, Sebastian L Johnston, et al.
Plos One|December 15, 2012
Identification of novel interacting partners of Sirtuin6Oxana Polyakova, Satty Borman, Rachel Grimley, et al.
Journal of Leukocyte Biology|February 14, 2020
A degradatory fate for CCR4 suggests a primary role in Th2 inflammationCaroline A Anderson, Pallavi Patel, Jonathan M Viney, et al.
Journal of Virology|August 8, 2014
Human rhinovirus 16 causes Golgi apparatus fragmentation without blocking protein secretionAurelie Mousnier, Dawid Swieboda, Anaïs Pinto, et al.
European Journal of Pharmacology|December 28, 2020
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replicationAndrea Marcellini, Dawid Swieboda, Anabel Guedán, et al.
Journal of Lipid Research|June 28, 2018
Host lipidome analysis during rhinovirus replication in HBECs identifies potential therapeutic targetsAn Nguyen, Anabel Guedán, Aurelie Mousnier, et al.
European Journal of Pharmacology|February 19, 2014
Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonistsLaura Ajram, Malcolm Begg, Robert Slack, et al.
BMC Pharmacology & Toxicology|March 2, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised studyAnthony Cahn, Simon Hodgson, Robert Wilson, et al.
Molecular Pharmacology|May 20, 2016
Latonduine Analogs Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 ActivityGraeme W Carlile, Renaud Robert, Elizabeth Matthes, et al.
Journal of Virology|February 24, 2017
Investigation of the Role of Protein Kinase D in Human Rhinovirus ReplicationAnabel Guedán, Dawid Swieboda, Mark Charles, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Antiviral Chemistry & Chemotherapy|April 20, 2013
The application of prophylactic antibodies for rhinovirus infectionsRiccardo Privolizzi, Roberto Solari, Sebastian L Johnston, et al.
Plos One|December 15, 2012
Identification of novel interacting partners of Sirtuin6Oxana Polyakova, Satty Borman, Rachel Grimley, et al.
Journal of Leukocyte Biology|February 14, 2020
A degradatory fate for CCR4 suggests a primary role in Th2 inflammationCaroline A Anderson, Pallavi Patel, Jonathan M Viney, et al.
Journal of Virology|August 8, 2014
Human rhinovirus 16 causes Golgi apparatus fragmentation without blocking protein secretionAurelie Mousnier, Dawid Swieboda, Anaïs Pinto, et al.
European Journal of Pharmacology|December 28, 2020
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replicationAndrea Marcellini, Dawid Swieboda, Anabel Guedán, et al.
Journal of Lipid Research|June 28, 2018
Host lipidome analysis during rhinovirus replication in HBECs identifies potential therapeutic targetsAn Nguyen, Anabel Guedán, Aurelie Mousnier, et al.
European Journal of Pharmacology|February 19, 2014
Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonistsLaura Ajram, Malcolm Begg, Robert Slack, et al.
BMC Pharmacology & Toxicology|March 2, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised studyAnthony Cahn, Simon Hodgson, Robert Wilson, et al.
Molecular Pharmacology|May 20, 2016
Latonduine Analogs Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 ActivityGraeme W Carlile, Renaud Robert, Elizabeth Matthes, et al.
Journal of Virology|February 24, 2017
Investigation of the Role of Protein Kinase D in Human Rhinovirus ReplicationAnabel Guedán, Dawid Swieboda, Mark Charles, et al.
Pageof 4